Quantity (per box / 10 vials)
A dual GIP/GLP-1 receptor agonist studied for appetite control, glucose regulation, and metabolic health.
Tirzepatide | 50 mg | 10 vials
A dual GIP/GLP-1 receptor agonist studied for appetite control, glucose regulation, and metabolic health.
Tirzepatide activates both GIP and GLP-1 receptors, bringing two important metabolic signaling pathways into one molecule. Researchers study how this dual action influences appetite, glucose regulation, insulin response, and body-weight biology. This product is intended for research use only.
Important Notice: Purchase and use of this product are restricted to laboratories and research organizations for laboratory research and scientific analysis only. It is not intended for human or animal use, consumption, or administration.
Tirzepatide activates both GIP and GLP-1 receptors, bringing two important metabolic signaling pathways into one molecule. Researchers study how this dual action influences appetite, glucose regulation, insulin response, and body-weight biology. This product is intended for research use only.
Important Notice: Purchase and use of this product are restricted to laboratories and research organizations for laboratory research and scientific analysis only. It is not intended for human or animal use, consumption, or administration.